2017 Press Releases
Page 1 of 4
-
3/10/2017
AG Jepsen Names Jane Rosenberg Connecticut's New Solicitor General
Attorney General George Jepsen today announced that long-time Assistant Attorney General Jane Rosenberg has been promoted within the Connecticut Office of the Attorney General to serve as an Associate Attorney General and the state's Solicitor General.
-
3/30/2017
Connecticut Joins Multistate Settlement Resolving Environmental Claims against Volkswagen for Emissions Fraud
Connecticut will receive $14,846,465 through a multistate settlement with auto-maker Volkswagen that resolves state claims that the company violated environmental laws when it equipped certain diesel vehicles with illegal and undisclosed emissions defeat devices designed to circumvent emissions standards, Attorney General George Jepsen said today.
-
3/20/2017
Attorney General Jepsen Provides Testimony in Support of Revising the Uniform Fraudulent Transfer Act
Attorney General George Jepsen today provided testimony to the legislature's Judiciary Committee in support of Senate Bill 1021, An Act Revising the Uniform Fraudulent Transfer Act, legislation that aims to prevent bankruptcy courts from ordering colleges and universities to pay back money parents or guardians had paid to send their children to college.
-
3/28/2017
AG Jepsen Joins Colleagues in Opposition to President Trump's Clean Power Plan Executive Order
Attorney General George Jepsen joined other state attorneys general and chief legal officers of several counties and cities in strongly opposing the executive order signed by President Donald Trump that rolls back the federal Environmental Protection Agency's (EPA) Clean Power Plan.
-
4/12/2017
AG Jepsen Urges Eligible Conn. Residents to Submit Claims for Provigil Settlement
Attorney General George Jepsen is urging Connecticut residents who may be eligible to participate in and receive funds from a $125 million multistate settlement that resolved anticompetitive conduct involving the drug Provigil to file a claim before time runs out.
-
4/13/2017
Statement from AG Jepsen on Governor Malloy's Announcement
"Governor Malloy and I took office together in 2011, and it has been an honor to serve alongside him as he has worked to address some of the most serious issues facing our state. His task has rarely been easy, but he has never faltered in his commitment to his office or to the people of Connecticut."
-
5/2/2017
AG Jepsen: Former Corinthian College Students Eligible for Federal Student Loan Cancellation
Attorney General George Jepsen announced today that Connecticut has joined at least 42 other states and the District of Columbia in notifying residents who attended schools operated by Corinthian Colleges, Inc. that they may be eligible for cancellation of their federal student loans used to attend those schools. If a student’s federal loan is cancelled, the student will make no more payments on the loan, and any payments already made will be refunded.
-
5/17/2017
Connecticut Files Lawsuit against EPA to Require Action on Petition to Reduce Emissions from Pennsylvania Coal Plant
Connecticut has filed a lawsuit in the United States District Court, District of Connecticut against the U.S. Environmental Protection Agency (EPA) for failure to take timely action on a petition from Connecticut’s Department of Energy and Environmental Protection (DEEP) asking the EPA to take action to stop pollution from a Pennsylvania coal-fired power plant from blowing our way.
-
5/23/2017
AG Jepsen: Conn. Leads $18.5M Settlement with Target Corporation over 2013 Data Breach
Attorney General George Jepsen today announced that Connecticut has joined with 46 other states and the District of Columbia in an $18.5 million settlement with the Target Corporation to resolve the states' investigation into the retail company's 2013 data breach. The settlement represents the largest multistate data breach settlement achieved to date.
-
10/31/2017
AG Jepsen Leads Coalition in New, Expanded Complaint in Federal Generic Drug Antitrust Lawsuit
Attorney General George Jepsen today led 45 other attorneys general taking part in a wide-ranging multistate antitrust investigation of the generic drug industry in asking the federal court for permission to file a new complaint in the states' pending lawsuit that increases the number of generic drug manufacturer defendants from six to 18 in the case and the number of drugs at issue in the litigation from two to 15.
-
11/17/2017
Consumer Alert: Beware Healthcare Scams during Open Enrollment
State officials today are warning Connecticut residents to look out for scammers using federal open enrollment periods to lure consumers into buying fake health plans or otherwise obtain personal or financial information, Attorney General George Jepsen, state Department of Insurance Commissioner Katharine Wade and Jim Wadleigh, CEO of Access Health CT, said today.
-
11/21/2017
AG Jepsen Announces New Head of Privacy & Data Security Department
Attorney General George Jepsen today announced that he has named Assistant Attorney General Jeremy Pearlman as head of his office's Privacy and Data Security Department.
-
11/27/2017
Statement from AG Jepsen on 2018 Race for Connecticut Attorney General
"It has been the greatest honor of my professional life to serve as Attorney General for the State of Connecticut."
-
12/8/2017
State-Federal Settlement Reached with Opioid Treatment Provider to Resolve Medicaid Overpayment Claim Allegations
A Connecticut healthcare organization and its chief executive officer have reached an $883,859 settlement with the state of Connecticut and the federal government to resolve allegations that the company submitted improper claims for payment to Connecticut's Medicaid program, Attorney General George Jepsen and state Department of Social Services (DSS) Commissioner Roderick L. Bremby said today.
-
12/20/2017
AG Jepsen, DCP: Conn. Joins $13.5 Million Multistate Settlement with Boehringer Ingelheim
Attorney General George Jepsen and state Department of Consumer Protection Commissioner Michelle H. Seagull today announced that Connecticut is joining with 49 other states and the District of Columbia in a $13.5 million settlement with Boehringer Ingelheim Pharmaceuticals, Inc. to resolve allegations that it engaged in off-label marketing and made deceptive and misleading representations in its promotion of four prescription drugs.
